Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 19/11/2008

    cr.appliance- integrated concepts in drug development

    Karen Grave-Hermann and Dr. Robert Hermann founded cr.applications in 2003. The two specialists who have wide-ranging experience in drug development talked to Michael Statnik about current trends in their field and about the development of the German biotech sector.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/cr-appliance-integrated-concepts-in-drug-development
  • Article - 08/11/2008

    Iron deficiency makes plants inventive

    Some heavy metals are trace elements that are necessary for the plants metabolism others are toxic in the smallest concentrations. Scientists from Hohenheim are investigating the mechanisms that plants use to adapt to specific soil situations.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/iron-deficiency-makes-plants-inventive
  • Article - 07/11/2008

    Living cells in focus

    Prof. Christoph Cremer Cremer hopes to use the Vertico-SMI nanoscope to decipher the molecular secrets of cells. After the 4Pi microscopy this system is the second development of his scientific career to break through the barrier of optical microscopy.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/living-cells-in-focus
  • Article - 27/09/2008

    First ratiopharm biosimilar to enter European market

    ratiopharm has been given approval by the EU regulatory office for its filgrastim biosimilar which will be launched in the fourth quarter of 2008. The company has already applied for market authorisation of another genetically engineered pharmaceutical.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/first-ratiopharm-biosimilar-to-enter-european-market
  • Article - 25/08/2008

    Rare kidney tumour leads the way to a new cancer therapy

    Renal cell carcinoma is a rare disease. In addition, the disease is difficult to treat, and the majority of pharmaceutical companies find the development of new drugs for its treatment too financially risky. Their argument: the market is too small to make up for the high development costs. The Tübingen biotech company immatics was courageous enough to do so and will now be rewarded. The immatics scientists have developed a therapy that not only…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/rare-kidney-tumour-leads-the-way-to-a-new-cancer-therapy
  • Article - 18/08/2008

    Vitamin D reduces mortality risk

    The medical importance of vitamin D calciferol is most likely even higher than suggested by recently published studies. A study which also involves the endocrinologist Bernhard Böhm from Ulm has attracted enormous attention as it suggests that vitamin D deficiency increases mortality.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/vitamin-d-reduces-mortality-risk
  • Article - 07/08/2008

    Patent Award 2008 – The Future Prize being offered by IP Bewertungs AG (IPB)

    An excellent idea: a new technology or innovative methods and products for which patents have been filed or already granted, might be eligible for the Patent Award 2008, a brand new prize, on offer for the first time in 2008. Due to the popularity of the prize, the application deadline has been extended to 30th September 2008.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/patent-award-2008-the-future-prize-being-offered-by-ip-bewertungs-ag-ipb
  • Article - 01/08/2008

    Nycomed - collaboration with Immunomedics

    Under the agreement Nycomed will receive the exclusive worldwide rights to develop manufacture and commercialise the subcutaneous formulation of veltuzumab for the treatment of all non-cancer indications.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-collaboration-with-immunomedics
  • Dossier - 15/07/2008 A group of pupils listening to a presentation.

    Science communication: why science is becoming more and more public

    Science needs publicity. Publicly funded research has to account for its projects internally as well as externally. In the past accounting for projects was a matter dealt with in courtly or academic circles today the forum is research journals. This internal communication seldom reaches the public however external communication seeks out the wider lay audience - for many reasons.

    https:////www.gesundheitsindustrie-bw.de/en/article/dossier/science-communication-why-science-is-becoming-more-and-more-public
  • Press release - 09/07/2008 At first, there was a lot of demand for small production batches; the picture shows a 250-l fermenter (Photo: Rentschler Biotechnologie)

    Rentschler to focus on biotechnology

    Rentschler has sold all its Rentschler Pharma GmbH shares to RIEMSER AG in Greifswald. With this move Rentschler is concentrating all its biotech activities at one site and thus providing the framework for further growth. In 2006 Rentschler sold its self-medication business.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/rentschler-to-focus-on-biotechnology
  • Press release - 23/06/2008

    PathoScan: Sowing clean seeds - and reaping a rich harvest

    Dr. Frank Brändle and Dr. Marco Thines managing directors of PathoScan GbR in Hohenheim have developed a PCR-based test system which allows the detection of fungi and bacteria in seed at very early stages. The test system will be patented in the near future.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/pathoscan-sowing-clean-seeds-and-reaping-a-rich-harvest
  • Article - 22/06/2008

    Nycomed sells oncology programs to 4SC

    Eight projects in the preclinical and first clinical stage will be transferred to 4SC. Nycomed decided not to further invest in oncology RD activities. 4SC develops drug candidates for inflammatory diseases cancer and infectious diseases.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-sells-oncology-programs-to-4sc
  • Press release - 20/05/2008

    A promising start into 2008

    In the first quarter of 2008 Nycomeds adjusted EBITDA increased by 6.2 to 304.0 million compared to 286.3 million in the first quarter of 2007 benefiting from the cost decreasing effects of last years restructuring.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/a-promising-start-into-2008
  • Article - 06/05/2008

    Vetter clients can concentrate fully on their core business

    The Ravensburg-based company Vetter Pharma-Fertigung GmbH & Co. KG is one of the leaders in biopharmaceutical contract manufacturing. We spoke with Max Horn, who has been with the company since 1981 and was appointed Managing Director in 2002.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/vetter-clients-can-concentrate-fully-on-their-core-business
  • Article - 20/04/2008

    Better convert knowledge into socio-economic benefits

    The European Commission adopted a Recommendation on the management of intellectual property in knowledge transfer activities of universities and other public research organisations. European organisations lag behind their North America counterparts.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/better-convert-knowledge-into-socio-economic-benefits
  • Article - 17/04/2008

    Targeted gene replacement in barley

    The GABI-PRECISE consortium which originates from the Genome Analysis of the Plant Biological System GABI initiative has announced a cooperative project on the introduction of gene targeting in barley.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/targeted-gene-replacement-in-barley
  • Press release - 08/04/2008

    Boehringer Ingelheim continues to grow

    Boehringer Ingelheim enjoyed continued success in 2007 and its growth is outpacing the pharmaceuticals market for the eighth year in a row. The companys turnover rose by 8.8 in local currency to almost EUR 11 billion.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/boehringer-ingelheim-continues-to-grow
  • Article - 19/03/2008

    Innovendia: Keeping the focus on client requirements

    The biotechnology sector is growing and new companies have excellent opportunities to establish themselves on the market. Dr. Michael Steinwand explains what companies have to beware.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/innovendia-keeping-the-focus-on-client-requirements
  • Article - 07/03/2008

    Establishment of the German Health Regions Network

    The German Health Regions Network association was instituted on the 14th February 2008. The association acknowledges the growing importance of the health care industry and hopes to strengthen it with a particular focus on the project-related cooperation between the German health regions.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/establishment-of-the-german-health-regions-network
  • Article - 01/03/2008

    Holger Barth is turning toxins into protein shuttles

    Holger Barth works with a special kind of Trojan horses. The toxicologist from Ulm is investigating bacterial toxins. These proteins manage in a similar way to the ancient Greeks before them to open the barricaded portal of the cells with a trick whereupon they start wreaking destruction.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/holger-barth-is-turning-toxins-into-protein-shuttles
  • Article - 24/02/2008

    Biametrics - High-tech analytics for the life sciences

    Biametrics Marken and Rechte GmbH has developed new analytical devices based on reflectometric interference spectroscopy thus adopting the trend of label-free detection methods. This is because labelling tends to interfere with the natural activity of the biomolecules under investigation.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/biametrics-high-tech-analytics-for-the-life-sciences
  • Press release - 20/02/2008

    ZRM and Naturin develop innovative biomembranes

    The Centre for Regenerative Biology and Medicine ZRM in Tübingen has joined forces with Naturin GmbH based in Weinheim. The partners plan to develop new carrier materials on the basis of collagen which improve cell cultures and medical implants.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/zrm-and-naturin-develop-innovative-biomembranes
  • Press release - 10/02/2008

    Nycomed’s Ciclesonide to be commercialised in the United States by Sepracor

    Nycomed has granted Sepracor Inc. NASDAQ SEPR the exclusive development marketing and commercialisation rights for Ciclesonide in the United States. Ciclesonide is Nycomeds patented corticosteroid with a novel principle of action.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-s-ciclesonide-to-be-commercialised-in-the-united-states-by-sepracor
  • Article - 10/02/2008 DAccepted the invitation to come to Reutlingen and talk about biomarkers (from left to right) - Mike Spain, Hanno Langen, Thomas Caskey, Larry Gold, Oliver Poetz, Thomas Joos und Hans Berger (Photo: NMI)

    4th Biomarker Workshop at the NMI in Reutlingen: another success

    The Biomarker Workshop held at the NMI in late January has become a fixed date for a growing number of proteomics researchers. With an attendance of 130 this years workshop exceeded all previous ones. Those who were keen to find out more about the latest trends and findings were presented with a successful mix of basic and applied research information.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/4th-biomarker-workshop-at-the-nmi-in-reutlingen-another-success
  • Press release - 09/02/2008

    Pharma and life sciences industry as growth sector

    The CEOs of pharmaceutical and life science companies are becoming increasingly aware that their companies are facing growing challenges and risks at the global level. At the same time they are also aware of more and more opportunities.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/pharma-and-life-sciences-industry-as-growth-sector

Page 6 / 7

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • sb_theme_biopro.domain.mdr-ivdr
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2021
Website address: https://www.gesundheitsindustrie-bw.de/en/search